| Ask4articles.info |
|
|
![]() |
TO THE EDITOR: We read with interes...TO THE EDITOR: We read with interest the article, "Necrotizing (Malignant) External Otitis," (1) according to Drs. Handzel and Halperin in the July 15 2003 issue of American Family Physician, and would like to existing our experience in the treatment of malignant external otitis. Between 1998 and 2003 nine patients (three women and six men) with a mean age of 648 years were treated for malignant external otitis at our department of otolaryngology. All treated patients had diseases that could affect their immune connected view such as diabetes (seven patients), leukemia (one patient), and bronchial asthma (one patient). Five of the nine patients had palsy of at least the same of the cranial nerves. Standard therapy included local treatment of the auditory canal, long-term systemic antibiotic therapy, radical mastoidectomy (two patients), and petrosectomy (one patient). Eight of the nine patients underwent hyperbaric oxygenation. common patient did not qualify for this treatment because of pulmonary contraindications. All eight patients received 100 percent oxygen in a multiplace chamber below 2.5 standard atmospheres of hurry (ATA) for 60 minutes (with pair five-minute breaks) once daily, five days a week. The press inside the hyperbaric chamber was achieved at compressed air. The total number of sessions hanged on clinical status. The mean number of hyperbaric oxygen sessions was 221 (range: 16 to 25 sessions). We received convenient results in all eight patients who were treated with hyperbaric oxygen Headache and discharge from the ear ceased, bacteriologic examinations of the ear swabs were negative, and changes in bone scintigraphy decreased; however, cranial brace palsy was still observed. Follow-up ranged from nine month to four years. Malignant external otitis is not a primary indication for hyperbaric oxygen according to the Undersea and Hyperbaric Medicine Society (UHMS) and the European Committee for Hyperbaric Medicine (ECHM) However, we originate hyperbaric oxygen very helpful in the adjunctive treatment of malignant external otitis because it prov to be effective in normalizing oxygen tension, which is necessary for the following: (1) destruction of bacteria through polymorpho-nuclear leucocytes; (2) stimulation of neo-vascular formation; and (3) stimulation of osteoclastic and osteoblastic activity. Our clinical observations confirm the experience of other authors. (2-6) The rarity of this disease makes it difficult to organize prospective, randomized, double-blind clinical trials that demonstrate the real benefits of hyperbaric oxygen in treating malignant external otitis. For this reason, any clinical experience and observations of this disease are of great value. REFERENCES (1) Handzel O Halperin D Necrotizing (malignant) external otitis. Am Fam Physician 2003;68:309-12 (2) Davis JC Gates GA, Lerner C Davis MG Jr Mader JT Dinesman A. Adjuvant hyperbaric oxygen in malignant external otitis. Arch Otolaryngol Head Neck Surg 1992;118:89-93 (3) Kuczkowski J Ozdzinski W Kowalska B Mikaszewski B Necrotizing malignant otitis--diagnostic and therapeutic moot points [in Polish]. In: Proceedings of the International Symposium "Rehabilitation in otology." Poznan, Poland;1999:99-102. (4) Pilgramm M Frey G Schumann K Hyperbaric oxygenation: a sensible adjunctive therapy in malignant external otitis [in German]. Laryngol Rhinol Otol [Stuttg] 1986;65:26-8 (5) Shupak A, Greenberg E Hardoff R Gordon C Melamed Y Meyer W Hyperbaric oxygenation for necrotizing (malignant) otitis externa. Arch Otolaryngol Head Neck Surg 1989;115:1470-5 (6) Tos M Malignant otitis externa In: Tos M ed Manual of middle ear surgery Vol 3 recent York: Georg Thieme Verlag, 1997:241-6 EDITOR'S NOTE: This note was sent to the authors of "Necrotizing (Malignant) External Otitis," who declined to reply EDITOR'S NOTE: This epistle was sent to the authors of "Necrotizing (Malignant) External Otitis," who declined to reply WALDEMAR NAROZNY, MD PHD JERZY KUCZKOWSKI, MD PHD BOGUSLAW MIKASZEWSKI, MD PHD Medical University of Gdansk Department of Otolaryngology Ul Debinki 7 put forth 16, 80-211 Gdansk, Poland COPYRIGHT 2004 American Academy of Family Physicians |
![]() |
Other Articles
-Feb. 1-8: Medicine of div...-Clinical Quiz questions a... -Jun. 18-21, 2003: WONCA r... -The surge of interest in ... -What kind of diet will he... -Oct. 1-5, 2003: New Orlea... -What does it take to lose... -Isolating persons infecte... -On page 77 of this issue,... -What should I eat when tr... -The U.S. Surgeon General'... -Echinacea is the name of ... -The Centers for Medicare ... -What is echinacea? Echi... -The navicular bone of the... -Technology-intensive chil... -A peer-reviewed, Web-base... -The 2003 Recommended Chil... -Diabetic patients who req... -The dryness of the skin's... -* Essure System. The U.S.... -The Centers for Disease C... -* Oats: you gotta love 'e... -The administration of inf... -Alabama Feb. 24-25: Spi... -The Cochrane Abstract bel... -The Department of Health ... -Clinical Quiz questions a... -Patients with hypertensio... -Jan. 17-19: Headache now ... -Case Scenario Yellowing... -Jun. 20-27: 7th diabetes ... -Monday We shouldn't tre... -Results of a new study by... -* Commit Lozenge. The Com... -A new report by the Insti... -This is one in a series e... -The Committee on Practice... -A new booklet of guidelin... -What is histoplasmosis? ... -Approximately 192,200 wom... -Monday "We promised her... -Histoplasmosis is an ende... -What is breast-conserving... -As someone who has had a ... -The Recommended Adult Imm... -Alaska May 16-18: Pract... -* Fashion could be harmfu... -Although celiac disease w... -Jan. 4-17: Communication ... -In a recent column, I men... -The interrupted horizonta... -Jun. 20-27: 7th diabetes ... -Jun. 18-21, 2003: WONCA r... -The article "Prealbumin: ... -Oct. 1-5, 2003: New Orlea... -The Department of Health ... -The Minnesota Health Tech... -The Agency for Healthcare... |
| . |